Company intelligence / Profile preview
Zyphars Pharmaceuticals
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
Overview
Zyphars Pharmaceuticals is an India-based pharmaceutical company specializing in the manufacturing, supply, and export of a wide range of pharmaceutical formulations. The company focuses on critical therapeutic segments including oncology, nephrology, hepatology, and critical care. Zyphars provides a broad portfolio of generic medicines, including oral solids and injectables, catering to both domestic and international markets. They are committed to providing high-quality, cost-effective treatment options for life-threatening conditions such as cancer and chronic kidney disease. The company maintains a strong presence in emerging markets through its robust export operations.
- Therapeutic areas
- OncologyNephrology
- Modalities
- Small moleculeMonoclonal antibody
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Zyphars Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zyphars Pharmaceuticals.